Cargando…

Molecular forms of prostate-specific antigen in the serum of women with benign and malignant breast diseases.

Using a highly sensitive immunofluorometric procedure, we measured the total prostate-specific antigen (PSA) concentration in 632 sera obtained from female blood donors and women with idiopathic hirsutism, breast cancer or benign breast diseases. A total of 50 sera with total PSA > 15 ng l(-1) we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borchert, G. H., Melegos, D. N., Tomlinson, G., Giai, M., Roagna, R., Ponzone, R., Sgro, L., Diamandis, E. P.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1997
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228085/ https://www.ncbi.nlm.nih.gov/pubmed/9376271

Ejemplares similares

Prostate-specific antigen in serum of women with breast cancer.
por: Giai, M., et al.
Publicado: (1995)

Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients.
por: Zarghami, N., et al.
Publicado: (1996)

Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues.
por: Howarth, D. J., et al.
Publicado: (1997)

Is Serum Prostate-specific Antigen a Diagnostic Marker for Benign and Malignant Breast Tumors in Women?
por: Razavi, Seyed Hasan Emami, et al.
Publicado: (2015)

Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women
por: Romppanen, J, et al.
Publicado: (1999)

Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis
por: Yousef, G M, et al.
Publicado: (2002)

Serum Oestradiol-17β in Women with Benign and Malignant Breast Disease
por: England, P. C., et al.
Publicado: (1974)

Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate
por: Agnihotri, Shalini, et al.
Publicado: (2014)

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia
por: Abotsi, Ebenezer, et al.
Publicado: (2022)

Association of the Serum Vascular Endothelial Growth Factor Levels With Benign Prostate Hyperplasia and Prostate Malignancies
por: Sharif, Mohammad Reza, et al.
Publicado: (2014)

Serum complexed and free prostate specific antigen levels are lower in female elite athletes in comparison to control women
por: Eklund, Emma, et al.
Publicado: (2017)

Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia
por: Kiebish, Michael A., et al.
Publicado: (2021)

Proceedings: Serum oestradiol 17 beta in normal premenopausal women and in patients with benign and malignant breast disease.
por: Skinner, L. G., et al.
Publicado: (1974)

The parallel lives of prostate specific antigen in cardiac troponin assays
por: Diamandis, Eleftherios P.
Publicado: (2023)

CD49f Is an Efficient Marker of Monolayer- and Spheroid Colony-Forming Cells of the Benign and Malignant Human Prostate
por: Yamamoto, Hidekazu, et al.
Publicado: (2012)

Hospitalization Decreases Serum Prostate-Specific Antigen Values Compared With Outpatient Values in Patients With Benign Prostatic Diseases
por: Yoon, In Seok, et al.
Publicado: (2013)

Amide Proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study
por: Yang, Lu, et al.
Publicado: (2023)

Combining Magnetic Resonance Diffusion-Weighted Imaging with Prostate-Specific Antigen to Differentiate Between Malignant and Benign Prostate Lesions
por: Han, Liying, et al.
Publicado: (2022)

Ebp1 expression in benign and malignant prostate
por: Gannon, Philippe O, et al.
Publicado: (2008)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
por: Putra, Ida Bagus O.W., et al.
Publicado: (2016)

Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease
por: Reis, I M, et al.
Publicado: (2015)

Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients
por: Kusuma Duarsa, Gede Wirya, et al.
Publicado: (2021)

Serum carcinoembryonic antigen elevation in benign lung diseases
por: Yang, Yi, et al.
Publicado: (2021)

MAGE, BAGE and GAGE: tumour antigen expression in benign and malignant ovarian tissue.
por: Gillespie, A. M., et al.
Publicado: (1998)

Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus
por: Sarwar, Shahana, et al.
Publicado: (2017)

Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women.
por: Bhathal, P. S., et al.
Publicado: (1985)

Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer.
por: Zarghami, N., et al.
Publicado: (1997)

Human kallikrein gene 13 (KLK13) expression by quantitative RT–PCR: an independent indicator of favourable prognosis in breast cancer
por: Chang, A, et al.
Publicado: (2002)

Impact of Treatment With Statins on Prostate-Specific Antigen and Prostate Volume in Patients With Benign Prostatic Hyperplasia
por: Lee, Sang Hun, et al.
Publicado: (2013)

Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia
por: Hsiao, Chun-Jen, et al.
Publicado: (2016)

Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer.
por: Sauter, Edward R, et al.
Publicado: (2002)

Comparative study of serum zinc concentrations in benign and malignant prostate disease: A Systematic Review and Meta-Analysis
por: Zhao, Jiang, et al.
Publicado: (2016)

Comparison of glutaminase and cancer antigen 125 for distinguishing benign and malignant ovarian tumors
por: Winarno, Gatot Nyarumenteng Adhipurnawan, et al.
Publicado: (2023)

Serum Carbohydrate Antigen 19-9 in Differential Diagnosis of Benign and Malignant Pancreatic Cystic Neoplasms: A Meta-Analysis
por: Cao, Shaobo, et al.
Publicado: (2016)

Benign or Malignant? Two Case Reports of Gigantic Prostatic Cyst
por: Yu, Jiang, et al.
Publicado: (2016)

Characterization of infiltrating lymphocytes in human benign and malignant prostate tissue
por: Rådestad, Emelie, et al.
Publicado: (2017)

Prostate imaging features that indicate benign or malignant pathology on biopsy
por: Lovegrove, Catherine Elizabeth, et al.
Publicado: (2018)

Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination
por: Yu, H, et al.
Publicado: (1999)

Prostatic Leiomyoma: An Uncommon Diagnosis Found in Clinically Suspected Cases of Severe Benign Prostatic Hyperplasia Without Elevated Serum Total Prostate-Specific Antigen Levels
por: Qiao, Jesse
Publicado: (2023)

Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
por: Nath, Chandan Kumar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_04jsngaontrbc3o29tek2a6sbh